Beatrice Eymin
Grenoble, 38000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose.
Journal: Acta pharmaceutica Sinica. B
Published: June 18, 2025
PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling.
PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling.
Journal: Life science alliance
Published: June 06, 2024
Targeting the spliceosome: A new therapeutic strategy to counteract chemotherapy resistance in lung cancer?
Journal: Revue des maladies respiratoires
Published: February 05, 2024
SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression.
Journal: NAR cancer
Published: February 24, 2023
Inspiratory hyperoxia: a new way to prevent metastasis through metabolism reprogramming in non-small cell lung cancer.
Journal: The European respiratory journal
Published: July 06, 2022
Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: February 04, 2022
Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer.
Journal: Molecular oncology
Published: November 18, 2021
Correction to: p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice.
Journal: Oncogene
Published: April 20, 2021
Last Updated: 09/26/2026